Benjamin J. Doranz

17.0k total citations · 5 hit papers
104 papers, 9.2k citations indexed

About

Benjamin J. Doranz is a scholar working on Infectious Diseases, Immunology and Virology. According to data from OpenAlex, Benjamin J. Doranz has authored 104 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Infectious Diseases, 37 papers in Immunology and 34 papers in Virology. Recurrent topics in Benjamin J. Doranz's work include HIV Research and Treatment (34 papers), Mosquito-borne diseases and control (31 papers) and Immune Cell Function and Interaction (28 papers). Benjamin J. Doranz is often cited by papers focused on HIV Research and Treatment (34 papers), Mosquito-borne diseases and control (31 papers) and Immune Cell Function and Interaction (28 papers). Benjamin J. Doranz collaborates with scholars based in United States, Belgium and France. Benjamin J. Doranz's co-authors include Robert W. Doms, Joseph Rucker, Marc Parmentier, Michel Samson, Ronald G. Collman, Stephen C. Peiper, Robert Smyth, Yanjie Yi, Joanne F. Berson and Benhur Lee and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Benjamin J. Doranz

104 papers receiving 9.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Dual-Tropic Primary HIV-1 Isolate That Uses Fusin and the β-Chemokine Receptors CKR-5, CKR-3, and CKR-2b as Fusion Cofactors

1996 1.6k citations Benjamin J. Doranz, Joseph Rucker et al. Cell profile →
Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8 ⁺ T cells

2013 454 citations Daniela Weiskopf, Michael A. Angelo et al. Proceedings of the National Academy of Sciences profile →
Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice

2016 295 citations Gopal Sapparapu, Nurgun Kose et al. profile →
Mxra8 is a receptor for multiple arthritogenic alphaviruses

2018 265 citations Julie M. Fox, Rachel H. Fong et al. profile →
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein

2021 215 citations Elad Binshtein, Mallorie E. Fouch et al. Cell profile →

Peers

Countries citing papers authored by Benjamin J. Doranz

Since Specialization

Citations

This map shows the geographic impact of Benjamin J. Doranz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin J. Doranz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin J. Doranz more than expected).

Fields of papers citing papers by Benjamin J. Doranz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin J. Doranz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin J. Doranz. The network helps show where Benjamin J. Doranz may publish in the future.

Co-authorship network of co-authors of Benjamin J. Doranz

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin J. Doranz. A scholar is included among the top collaborators of Benjamin J. Doranz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin J. Doranz. Benjamin J. Doranz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A VHH single-domain platform enabling discovery and development of monospecific antibodies and modular neutralizing bispecifics against SARS-CoV-2 variants 2024 ·PubMed ·(unknown), Tom Z. Yuan, (unknown), Lin Ding, (unknown), (unknown), (unknown), (unknown), Edgar Davidson, Benjamin J. Doranz, Kartik Chandran, Emily Happy Miller, Jessica A. Plante, Scott C. Weaver, (unknown), Shweta Kailasan, (unknown), (unknown), Yasmina Abdiche, Aaron K. Sato	1
2	1431 Developing an FDA-qualified drug development tool, the membrane proteome array, for specificity testing of antibodies and CAR-T cell therapies 2023 ·SHILAP Revista de lepidopterología ·(unknown), Michael Phelan, Diana M. Norden, (unknown), (unknown), Rachel H. Fong, Amrita Singh, Benjamin J. Doranz	1
3	Single B cell transcriptomics identifies multiple isotypes of broadly neutralizing antibodies against flaviviruses 2023 ·PLoS Pathogens ·(unknown), (unknown), Duncan Ralph, (unknown), Maya Contreras, (unknown), (unknown), (unknown), Edgar Davidson, Verónica Durán, (unknown), Ana María Sanz, Fernando Rosso, Benjamin J. Doranz, Shirit Einav, F. A. Matsen, Leslie Goo	6
4	Breaking barriers in antibody discovery: harnessing divergent species for accessing difficult and conserved drug targets 2023 ·mAbs ·Soma S. R. Banik, Natasha Kushnir, Benjamin J. Doranz, Ross Chambers	3
5	Somatic Hypermutation and Framework Mutations of Variable Region Contribute to Anti-Zika Virus-Specific Monoclonal Antibody Binding and Function 2022 ·Journal of Virology ·Isamu Tsuji, Fue Vang, (unknown), (unknown), (unknown), Jill A. Livengood, Edgar Davidson, Mallorie E. Fouch, Benjamin J. Doranz, Subash C. Das, Hansi Dean	5
6	Optimal therapeutic activity of monoclonal antibodies against chikungunya virus requires Fc-FcγR interaction on monocytes 2019 ·Science Immunology ·Julie M. Fox, Vicky Roy, Bronwyn M. Gunn, Ling Huang, Melissa A. Edeling, Matthias Mack, Daved H. Fremont, Benjamin J. Doranz, Syd Johnson, Galit Alter, Michael Diamond	58
7	Human antibody response to Zika targets type-specific quaternary structure epitopes 2019 ·JCI Insight ·Matthew H. Collins, (unknown), Ciara Gimblet, (unknown), Ramesh Jadi, Stefan Metz, (unknown), Benjamin D. McElvany, Edgar Davidson, Benjamin J. Doranz, Yaoska Reyes, Natalie M. Bowman, Sylvia Becker‐Dreps, Filemón Bucardo, Helen M. Lazear, Sean A. Diehl, Aravinda M. de Silva	38
8	Potent neutralizing antibodies elicited by dengue vaccine in rhesus macaque target diverse epitopes 2019 ·PLoS Pathogens ·Leike Li, Weixu Meng, Melanie Horton, (unknown), Elizabeth Thoryk, Jennifer M. Pfaff, Qihui Wang, Georgina To’a Salazar, Trevor Barnes, Benjamin J. Doranz, Andrew J. Bett, Danilo R. Casimiro, Kalpit A. Vora, Zhiqiang An, Ningyan Zhang	30
9	Isolation of state-dependent monoclonal antibodies against the 12-transmembrane domain glucose transporter 4 using virus-like particles 2018 ·Proceedings of the National Academy of Sciences ·David Tucker, Jonathan T. Sullivan, (unknown), Christine R. Fisher, Trevor Barnes, Manu Mabila, (unknown), Chidananda Sulli, (unknown), Riley Payne, (unknown), (unknown), Xiaoxiang Deng, Edgar Davidson, Sharon H. Willis, Benjamin J. Doranz, Ross Chambers, Joseph Rucker	48
10	Human antibody recognition of antigenic site IV on Pneumovirus fusion proteins 2018 ·PLoS Pathogens ·Jarrod J. Mousa, Elad Binshtein, Stacey Human, Rachel H. Fong, Gabriela Alvarado, Benjamin J. Doranz, Martin L. Moore, Melanie D. Ohi, James E. Crowe	29
11	Elevating the Value of mAbs using Epitope Mappings 2017 ·Genetic Engineering & Biotechnology News ·Soma S. R. Banik, Xiaoxiang Deng, Benjamin J. Doranz	2
12	Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to Dengue Virus Serotype 4 Infection and Vaccination 2016 ·Journal of Virology ·Usha K. Nivarthi, Nurgun Kose, Gopal Sapparapu, Douglas G. Widman, Emily N. Gallichotte, Jennifer M. Pfaff, Benjamin J. Doranz, Daniela Weiskopf, Alessandro Sette, Anna P. Durbin, (unknown), Ralph S. Baric, James E. Crowe, Aravinda M. de Silva	39
13	Functional Transplant of a Dengue Virus Serotype 3 (DENV3)-Specific Human Monoclonal Antibody Epitope into DENV1 2016 ·Journal of Virology ·William B. Messer, Boyd L. Yount, Scott R. Royal, Ruklanthi de Alwis, Douglas G. Widman, Scott A. Smith, James E. Crowe, Jennifer M. Pfaff, Kristen M. Kahle, Benjamin J. Doranz, Kristie D. Ibarra, Eva Harris, Aravinda M. de Silva, Ralph S. Baric	26
14	Screening the Membrane Protein 2016 ·Genetic Engineering & Biotechnology News ·(unknown), Soma S. R. Banik, Benjamin J. Doranz	3
15	Optimizing Membrane Protein Expression 2015 ·Genetic Engineering & Biotechnology News ·Benjamin J. Doranz, Soma S. R. Banik	1
16	Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8 ⁺ T cells breakdown → 2013 ·Proceedings of the National Academy of Sciences ·Daniela Weiskopf, Michael A. Angelo, Elzinandes Leal de Azeredo, John Sidney, Jason Greenbaum, Anira N. Fernando, Anne Broadwater, Ravi V. Kolla, Aruna Dharshan De Silva, Aravinda M. de Silva, (unknown), Benjamin J. Doranz, Howard M. Grey, Sujan Shresta, Bjoern Peters, Alessandro Sette	454
17	Dengue Reporter Virus Particles for Measuring Neutralizing Antibodies against Each of the Four Dengue Serotypes 2011 ·PLoS ONE ·(unknown), Bridget A. Puffer, Katherine L. Williams, (unknown), (unknown), (unknown), (unknown), Sandya Ajith, (unknown), Eli Berdougo, Eva Harris, Benjamin J. Doranz	60
18	Measuring Membrane Protein Interactions Using Optical Biosensors 2010 ·Methods in molecular biology ·Joseph Rucker, (unknown), Benjamin J. Doranz	6
19	Safe Use of the CXCR4 Inhibitor ALX40-4C in Humans 2001 ·AIDS Research and Human Retroviruses ·Benjamin J. Doranz, L G Filion, Francisco Díaz‐Mitoma, Daniel Sitar, Jan Sahai, Frédéric Baribaud, Michael J. Orsini, Jeffrey Benovic, D. William Cameron, Robert W. Doms	89
20	A Dual-Tropic Primary HIV-1 Isolate That Uses Fusin and the β-Chemokine Receptors CKR-5, CKR-3, and CKR-2b as Fusion Cofactors breakdown → 1996 ·Cell ·Benjamin J. Doranz, Joseph Rucker, Yanjie Yi, Robert Smyth, Michel Samson, Stephen C. Peiper, Marc Parmentier, Ronald G. Collman, Robert W. Doms	1580

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact